Baxter International Inc. (NYSE:BAX) Shares Sold by Trust Co. of Toledo NA OH

Trust Co. of Toledo NA OH cut its position in Baxter International Inc. (NYSE:BAX) by 23.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,443 shares of the medical instruments supplier’s stock after selling 4,470 shares during the quarter. Trust Co. of Toledo NA OH’s holdings in Baxter International were worth $421,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Geode Capital Management LLC boosted its stake in shares of Baxter International by 1.4% in the third quarter. Geode Capital Management LLC now owns 12,156,660 shares of the medical instruments supplier’s stock valued at $460,022,000 after purchasing an additional 170,776 shares during the period. Entropy Technologies LP boosted its stake in Baxter International by 213.5% during the 3rd quarter. Entropy Technologies LP now owns 23,192 shares of the medical instruments supplier’s stock valued at $881,000 after acquiring an additional 15,794 shares during the last quarter. Toronto Dominion Bank boosted its stake in Baxter International by 15.4% during the 3rd quarter. Toronto Dominion Bank now owns 170,855 shares of the medical instruments supplier’s stock valued at $6,487,000 after acquiring an additional 22,787 shares during the last quarter. Sivik Global Healthcare LLC boosted its stake in Baxter International by 50.0% during the 3rd quarter. Sivik Global Healthcare LLC now owns 150,000 shares of the medical instruments supplier’s stock valued at $5,696,000 after acquiring an additional 50,000 shares during the last quarter. Finally, Coho Partners Ltd. bought a new position in Baxter International during the 3rd quarter valued at $57,229,000. 90.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have commented on BAX. Stifel Nicolaus reduced their price objective on shares of Baxter International from $46.00 to $38.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Citigroup reduced their price objective on shares of Baxter International from $37.00 to $35.00 and set a “neutral” rating on the stock in a research note on Wednesday, December 11th. Finally, StockNews.com downgraded shares of Baxter International from a “buy” rating to a “hold” rating in a research report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $40.45.

Baxter International Stock Up 3.5 %

BAX stock opened at $30.46 on Tuesday. The company has a quick ratio of 1.09, a current ratio of 1.43 and a debt-to-equity ratio of 1.31. Baxter International Inc. has a fifty-two week low of $28.33 and a fifty-two week high of $44.01. The firm’s 50-day simple moving average is $31.47 and its 200 day simple moving average is $34.78. The stock has a market cap of $15.55 billion, a PE ratio of 152.31, a price-to-earnings-growth ratio of 12.74 and a beta of 0.59.

Baxter International (NYSE:BAX) last released its quarterly earnings data on Friday, November 8th. The medical instruments supplier reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.02. Baxter International had a net margin of 0.77% and a return on equity of 18.30%. The business had revenue of $3.85 billion for the quarter, compared to analysts’ expectations of $3.85 billion. During the same quarter last year, the company earned $0.68 EPS. The company’s revenue for the quarter was up 3.8% compared to the same quarter last year. As a group, sell-side analysts predict that Baxter International Inc. will post 1.92 EPS for the current year.

Baxter International Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were issued a $0.17 dividend. The ex-dividend date was Friday, November 29th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.23%. Baxter International’s dividend payout ratio (DPR) is presently 340.00%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.